Skip to Content
Print Save

M 14 (Methotrexate Sodium 2.5 mg)

Pill with imprint M 14 is Orange, Round and has been identified as Methotrexate Sodium 2.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Methotrexate is used in the treatment of acute lymphocytic leukemia; acute lymphoblastic leukemia; rheumatoid arthritis; systemic sclerosis; solid tumors and belongs to the drug classes antimetabolites, antipsoriatics, antirheumatics, other immunosuppressants. Not for use in pregnancy. Methotrexate 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 14

Methotrexate sodium 2.5 mg M 14
Methotrexate sodium 2.5 mg M 14 Front
Methotrexate sodium 2.5 mg M 14 Back
Methotrexate sodium 2.5 mg M 14

Methotrexate Sodium

Imprint
M 14
Strength
2.5 mg
Color
Orange
Size
6.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimetabolites, Antipsoriatics, Antirheumatics, Other immunosuppressants
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, corn starch, sodium carbonate monohydrate, sodium lauryl sulfate, sodium starch glycolate type A potato, FD&C Red No. 40

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-0014 Mylan Pharmaceuticals Inc.
51079-0670 UDL Laboratories Inc.
More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "M 14"

Celecoxib
Clonazepam
Omeprazole Delayed-Release

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer